Canada Markets closed

Global Immunohematology Tests Devices Pipeline Market Landscape Report 2021 - ResearchAndMarkets.com

·3 min read

DUBLIN, December 08, 2021--(BUSINESS WIRE)--The "Immunohematology Tests - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information about the Immunohematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunohematology Tests includes studies of antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. This category includes blood typing reagents and antibody detection reagents.

Scope

  • Extensive coverage of the Immunohematology Tests under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Immunohematology Tests and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand important and diverse types of Immunohematology Tests under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Immunohematology Tests Overview

3 Products under Development

3.1 Immunohematology Tests - Pipeline Products by Stage of Development

3.2 Immunohematology Tests - Pipeline Products by Segment

3.3 Immunohematology Tests - Pipeline Products by Territory

3.4 Immunohematology Tests - Pipeline Products by Regulatory Path

3.5 Immunohematology Tests - Pipeline Products by Estimated Approval Date

4 Immunohematology Tests - Pipeline Products under Development by Companies

4.1 Immunohematology Companies - Pipeline Products by Stage of Development

4.2 Immunohematology Tests - Pipeline Products by Stage of Development

5 Immunohematology Companies and Product Overview

5.1 AbSorber AB Company Overview

5.1.1 AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview

5.2 Alba Bioscience Limited Company Overview

5.3 Amity University Company Overview

5.4 Biofortuna Ltd Company Overview

5.5 Calviri Inc Company Overview

5.6 Grifols SA Company Overview

5.7 Ortho Clinical Diagnostics Holdings Plc Company Overview

5.8 Quotient Ltd Company Overview

5.9 SiDx Inc Company Overview

5.10 Transfusion & Transplantation Technologies (Inactive) Company Overview

6 Immunohematology- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/7gxnk6

View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005769/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting